NSF's Neal Lane: In Pursuit Of `Strategic Basic Research'

Editor's Note: As Neal Lane settles into his new job as director of the National Science Foundation, his enthusiasm is tempered by a clear understanding of the formidable challenges facing him, his agency, and the United States research community in general. While confident that the nation can maintain its scientific leadership internationally, the 55-year-old physicist and former Rice University provost acknowledges that, if Ameri

Written byFranklin Hoke
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

While confident that the nation can maintain its scientific leadership internationally, the 55-year-old physicist and former Rice University provost acknowledges that, if American science is to fulfill its mission, it must do so in the context of a rapidly changing global environment, with all countries seeking to reshape and reidentify themselves in the post-Cold War world.

Foremost among NSF's objectives, Lane contends, is the identification and support of scientific endeavors that accommodate both the individual investigator's inclination to pursue pure research and the nation's need for applications of scientific discovery. Such applications could come, for example, in the form of advanced technology and commercial products that shore up America's commanding position in the increasingly competitive world economy.

In discussing agency goals in this regard, Lane uses the phrase "strategic basic research"--an idea that may well serve him in his efforts to balance pressures from Congress for NSF to do more ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies